Article

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19

2022-03-11

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold>Autoantibodies (aAbs) to type I interferons (IFNs) have been found in <1% of individuals under the age of 60 in the general population, with the prevalence increasing among those over 65. Neutralizing autoantibodies (naAbs) to type I IFNs have been found in at least 15% of patients with life-threatening COVID-19 pneumonia in several cohorts of primarily European desc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2f3e2cc1-b849-56ce-bc92-1c3cd8e65a0f
DOI: 10.21203/rs.3.rs-1430985/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19DOI 10.21203/rs.3.rs-1430985/v1Read

The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesSemantic proximity Read

Interferon system deficiencies exacerbating severe pandemic virus infections.Semantic proximity Read

Interfering with Interferons: A Critical Mechanism for Critical COVID-19 PneumoniaSemantic proximity Read

Type I interferons in health and disease: molecular aspects and clinical implicationsSemantic proximity Read

Defective type I interferon immunity is associated with increasing COVID-19 severitySemantic proximity Read

Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activitySemantic proximity Read

Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19Semantic proximity Read

Predominance of Distinct Autoantibodies in Response to SARS-CoV-2 InfectionSemantic proximity Read

Highly-sensitive reporter cell line for detection of interferon types I-III and their neutralization by antibodiesSemantic proximity Read

Autoantibodies neutralizing type I interferons underlie a third of cases of Chikungunya virus encephalitis or myelitisSemantic proximity Read

Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors.Semantic proximity Read

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsSemantic proximity Read